Cargando…
The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
BACKGROUND: This meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD). METHODS: PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies publ...
Autores principales: | Li, Jiaxuan, Wu, Xin, Tan, Xin, Wang, Shixin, Qu, Ruisi, Wu, Xiaofeng, Chen, Zhouqing, Wang, Zhong, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661413/ https://www.ncbi.nlm.nih.gov/pubmed/38020763 http://dx.doi.org/10.3389/fnagi.2023.1257973 |
Ejemplares similares
-
The efficacy and safety of general anesthesia vs. conscious sedation for endovascular treatment in patients with acute ischemic stroke: a systematic review and meta-analysis
por: Zhao, Jiashuo, et al.
Publicado: (2023) -
The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023) -
Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer’s disease
por: Ben-Ami, Liat, et al.
Publicado: (2023) -
A Conceptual View of Cognitive Intervention in Older Adults With and Without Cognitive Decline—A Systemic Review
por: Mendes, Liliana, et al.
Publicado: (2022) -
Rich-Club Organization Disturbances of the Individual Morphological Network in Subjective Cognitive Decline
por: Peng, Liling, et al.
Publicado: (2022)